Analysts have recently evaluated Chart Industries and provided 12-month price targets. The average target is $217.0, accompanied by a high estimate of $250.00 and a low estimate of $165.00. Observing ...
Allegheny County Controller and mayoral challenger Corey O’Connor said today that “shoddy math and irresponsible decisions” ...
US manufacturers are increasingly nervous about President Trump’s tariffs. They’re already disrupting supply chains, and the ...
Finarb Analytics Consulting, a leading provider of data and AI solutions, is set to launch DataXpert, a next-generation Generative AI platform poised to transform enterprise analytics. Discover more ...
China’s Low-Carbon City Pilot (LCCP) policy significantly improved urban energy-environmental efficiency, especially in eastern and large cities. The policy’s success is driven by industrial ...
6h
Zacks Investment Research on MSNHere is What to Know Beyond Why Aptiv PLC (APTV) is a Trending StockAptiv PLC (APTV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...
6h
Zacks Investment Research on MSNPowell Industries, Inc. (POWL) is Attracting Investor Attention: Here is What You Should KnowPowell Industries (POWL) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
The 25,221-pound model has a standard two-piece articulated boom and 360-degree swing capability for tight jobsites. Details ...
The global pet food processing market size was US$ 5.1 billion in 2021. The global pet food processing market is forecast to grow to US$ 7.9 billion by 2030 by registering a compound annual growth ...
The global commercial greenhouse market size was US$ 31.1 billion in 2021. The global commercial greenhouse market is forecast to grow to US$ 85.9 billion by 2030 by growing at a compound annual ...
Revenue of $62.3 Million In-Line with Revised Revenue Guidance Continued to Diversify Customer Base with Leading Sell-Side Partners and Buy-Side Customers ...
INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results